Delivery Order SPE2DB20D3103-SPE2DB22FL7N3
Award Date 11/22/21
Potential Completion Date 11/23/21
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $15,594.00 firm fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty medication. The award has an ultimate completion date of August 1, 2024. This contract is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This federal contract award is a $1,097.50 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a medication, with a performance period through June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
- This federal contract award, valued at $8,386.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical,...
- This contract award, with a ceiling value of $24,456.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award, valued at $9,547.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a critical medication used in various medical treatments. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award (SPE2DB20D3103|SPE2DB23FM6W2) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,179,488 units of the drug GONAL-F RFF REDI-JECT 900. The contract, valued at $17,832.83, is a firm fixed-price delivery order with a completion date of March 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.62 firm fixed-price contract, awarded on November 5, 2024, is for the delivery of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a pharmaceutical product, with a performance period through November 6, 2024. This is a delivery order contract, and no set-aside designation was used. Amerisourcebergen Drug Corp...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product, with a ceiling value of $136,146.74 and a period of performance through January 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, suggesting open competition....
- This federal contract award is for the delivery of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML pharmaceuticals to the Defense Logistics Agency (DLA). The $1,493.60 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 7, 2024, with a completion date of November 8, 2024. This contract is a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a pharmaceutical product. The contract has a firm fixed price of $1,097.52 and a completion date of June 12, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...